SSKN News and Press, Strata Skin Sciences Inc. From 07/25/22

Strata Skin Sciences ( NASDAQ: SSKN ) on Monday announced the U.S. commercial launch of its acne treatment TheraClear X. Shares of the company soared ~18% after hours to $1.39. The company said the TheraClearX Acne Therapy System is engineered and indicated spe...

HORSHAM, Pa., July 25, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the U.S. commercial launch of Ther...

HORSHAM, Pa., June 07, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced today that it will be participating in t...

HORSHAM, Pa., May 16, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that Michael E. Goodman has been na...

The following slide deck was published by STRATA Skin Sciences, Inc. in conjunction with their 2022 Q1 earnings call. For further details see: STRATA Skin Sciences, Inc. 2022 Q1 - Results - Earnings Call Presentation

STRATA Skin Sciences, Inc. (SSKN) Q1 2022 Earnings Conference Call May 11, 2022 04:30 PM ET Company Participants Leigh Salvo - Investor Relations Robert Moccia - Chief Executive Officer Christopher Lesovitz - Chief Financial Officer Conference Call Participants Destiny Alexandra Buch - Ladenb...

STRATA Skin Sciences press release (NASDAQ:SSKN): Q1 GAAP EPS of -$0.07. Revenue of $7M (+20.1% Y/Y). FY22 revenue expected to be in the range of $33.0M to $35.0M. For further details see: STRATA Skin Sciences GAAP EPS of -$0.07, revenue of $7M

HORSHAM, Pa., May 11, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced financial results for the first qua...

HORSHAM, Pa., April 27, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced that it plans to release its firs...

HORSHAM, Pa., March 30, 2022 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of various autoimmune skin diseases, today announced that it has become...